Viewing Study NCT00308256



Ignite Creation Date: 2024-05-05 @ 4:45 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00308256
Status: COMPLETED
Last Update Posted: 2011-12-30
First Post: 2006-03-28

Brief Title: Effects of Nurse-counselling in the Improvement of the type1 Diabetes Control in Adolescents
Sponsor: Hospices Civils de Lyon
Organization: Hospices Civils de Lyon

Study Overview

Official Title: Effects of Nurse-counselling in the Improvement of the type1 Diabetes Control in Adolescents a Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2011-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The incidence of type 1 diabetes is increasing in France A recent cross sectional study has shown that in France only 15 of children and 26 of adults had HbA1c7 Adolescents seem to need particularly a better metabolic control

Working Hypothesis

We hypothesized that a stricter control of glycaemia by nurse-counselling could probably improve metabolic control in adolescents with type 1 diabetes

Objectives

To show that nurse-counselling may improve levels of patient satisfaction

Methodology

The main criterion is the patient acceptance of diabetes measured by an analogical visual scale rated from 0 I cope very well with my diabetes I cope very badly with my diabetes to 10 cm The scale will be measured every quarter within 12 months follow-up We wish to improve patients appreciation by 10 mm near to I cope very well with my diabetes

This is a randomised parallel group study with 36 subjects in each group During the follow-up the routine follow-up group will continue its routine care The complementary follow-up group will be called by nurses every 15 days and consult monthly HbA1c is the secondary criterion and will be measured every 3 months

The total study duration is 18 months including 6 months for the recruitment and 12 months for the patients follow-up
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None